Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Global Biotech

+ Add to Watchlist

ADGLBIA:SW

1,885.87 CHF 59.99 3.08%

As of 11:24:00 ET on 05/16/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Adamant Global Biotech (ADGLBIA)

Year To Date: +43.86% 3-Month: +32.19% 3-Year: - 52-Week Range: 1,237.77 - 1,951.64
1-Month: +14.76% 1-Year: +45.50% 5-Year: - Beta vs SMI: 0.93

Mutual Fund Chart for ADGLBIA

No chart data available.
  • ADGLBIA:SW 1,885.87
  • 1M
  • 1Y
Interactive ADGLBIA Chart

Previous Close

Fund Profile & Information for ADGLBIA

Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.

Inception Date: 10-15-2010 Telephone: +41 800 850 050
Managers: -
Web Site: www.zkb.ch/fonds

Fundamentals for ADGLBIA

NAV (on 2013-05-16) 1,885.87
Assets (M) (on 2013-05-16) 123.77
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for ADGLBIA

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ADGLBIA

Front Load 2.50
Back Load 1.00
Current Mgmt Fee 1.80
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.83

Top Fund Holdings for ADGLBIA

Filing Date: 01/31/2013
Name Position Value % of Total
Regeneron Pharmaceuticals Inc 49,500 7,839,432 8.777%
Amgen Inc 90,000 7,003,020 7.840%
Celgene Corp 75,000 6,757,731 7.566%
Gilead Sciences Inc 186,000 6,680,976 7.480%
Biogen Idec Inc 43,000 6,110,766 6.841%
Perrigo Co 57,000 5,216,318 5.840%
Alexion Pharmaceuticals Inc 59,954 5,130,737 5.744%
Vertex Pharmaceuticals Inc 76,500 3,119,073 3.492%
Salix Pharmaceuticals Ltd 70,000 3,052,907 3.418%
BioMarin Pharmaceutical Inc 53,000 2,648,799 2.966%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil